Radiotherapy for prevention and therapy of gynecomastia due to antiandrogen treatment in prostate cancer patients: A patterns-of-care study

Strahlentherapie und Onkologie

Volumn 187, Issue 12, 2011, Pages 771-777

  Neu, Burkhard ^a   Sautter, Verena ^a   Momm, Felix ^b   Melcher, Ute ^a   Seegenschmiedt, Heinrich ^c   Micke, Oliver ^d   Sautter Bihl, Marie Luise ^a  

^a STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Strahlenzentrum Hamburg   (Germany)

^d FRANZISKUS HOSPITAL   (Germany)

Author keywords

Antiandrogen therapy; Gynecomastia; Prostate cancer; Radiotherapy; Tamoxifen

Indexed keywords

ANTIANDROGEN; ANTIESTROGEN; BICALUTAMIDE; ESTROGEN; TAMOXIFEN;

ARTICLE; AUSTRIA; CANCER PATIENT; CLINICAL TRIAL; ELECTRON BEAM; ERYTHEMA; GERMANY; GYNECOMASTIA; HUMAN; HYPERPIGMENTATION; MAJOR CLINICAL STUDY; PHOTON THERAPY; PROSPECTIVE STUDY; PROSTATE CANCER; QUESTIONNAIRE; RADIATION DOSE; SWITZERLAND; X RAY;

ANDROGEN ANTAGONISTS; AUSTRIA; DOSE FRACTIONATION; FOLLOW-UP STUDIES; GERMANY; GYNECOMASTIA; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIODERMATITIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SWITZERLAND; TREATMENT OUTCOME;

EID: 84856232198     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-2283-x     Document Type: Article

References (30)

1. O. Alfthan K. Kettunen 1965 The effect of roentgen ray treatment of gynecomastia in patients with prostatic carcinoma treated with estrogenic hormones: a preliminary communication J Urol 94 604 606 5846201 1:STN:280:DyaF28%2FksFyntw%3D%3D
2. F. Boccardo 2005 Rubagotti A, Battaglia M et al. Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer J Clin Oncol 23 808 815 15681525 10.1200/JCO.2005.12.013 1:CAS:528:DC%2BD2MXitVKit74%3D (Pubitemid 46224180)
3. J.L. Chou J.D. Easley J.J. Feldmeier, et al. 1988 Effective radiotherapy in palliating mammalgia associated with gynecomastia after DES therapy Int J Radiat Oncol Biol Phys 15 749 751 2458332 10.1016/0360-3016(88)90321-5 1:STN:280:DyaL1czjtVGhtA%3D%3D
4. F. Cuppone E. Bria D. Giannarelli, et al. 2010 Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: metaanalysis of randomized trials BMC Cancer 10 675 21143897 10.1186/1471-2407-10-675
5. A.P. Dicker 2003 The safety and tolerability of low-dose irradiation for the management of gynaecomastia caused by antiandrogen monotherapy Lancet Oncol 4 30 36 12517537 10.1016/S1470-2045(03)00958-6 (Pubitemid 36124188)
6. A. Dobs M.J. Dark 2005 Incidence and management of gynecomastia in men treated for prostate cancer J Urol 174 1737 1742 16217274 10.1097/01.ju. 0000176461.75794.f8 (Pubitemid 41546924)
7. D.J. Fass A. Steinfeld J. Brown, et al. 1986 Radiotherapeutic prophylaxis of estrogen-induced gynecomastia: a study of late sequela Int J Radiat Oncol Biol Phys 12 407 408 3957739 10.1016/0360-3016(86)90359-7 1:STN:280: DyaL287mslKrsA%3D%3D (Pubitemid 16108871)
8. J.F. Fowler 1992 Brief summary of radiobiological principles in fractionated radiotherapy Sem Radiat Oncol 2 16 21 10.1016/S1053-4296(05)80045-1
9. Y. Fradet B. Egerdie M. Andersen, et al. 2007 Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-responde study Eur Urol 52 106 115 17270340 10.1016/j.eururo.2007.01.031 1:CAS:528:DC%2BD2sXotFyltr0%3D (Pubitemid 46823894)
10. H. Geinitz R. Thamm C. Scholz, et al. 2010 Longitudinal analysis of quality of life in patients receiving conformal radiation therapy for prostate cancer Strahlenther Onkol 186 46 52 20082188 10.1007/s00066-009-2023-7
11. R. Graf D. Boehmer V. Budach, et al. 2010 Residual transloational and rotational errors after kV X-ray image-guided correction of prostate lodation using implanted fiducials Strahlenther Onkol 186 544 550 20936461 10.1007/s00066-010-2030-8
12. M. Guckenberger S. Ok B. Polat, et al. 2010 Toxicity after intensity-modulated, image- guided radiotherapy for prostate cancer Strahlenther Onkol 186 535 543 20890743 10.1007/s00066-010-2144-z
13. G. Di Lorenzo S. Perdona S. de Placido, et al. 2005 Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy J Urol 174 2197 2203 16280763 10.1097/01.ju.0000181824.28382.5c (Pubitemid 41611773)
14. D.G. McLeod P. Iverson 2000 Gynecomastia in patients with prostate cancer: a review of treatment options Urology 56 713 720 11068286 10.1016/S0090-4295(00)00823-2 1:STN:280:DC%2BD3crhtlWmtg%3D%3D
15. H. Metzger A. Junker A.C. Voss 1980 Die Bestrahlung der Brustdrüsen als Prophylaxe der östrogeninduzierten Gynäkomastie beim Prostatakarzinom Strahlenther 156 102 104 1:STN:280:DyaL3c7isVyqsQ%3D%3D (Pubitemid 10157246)
16. C. Nieder A. Pawinski N.H. Andratschke, et al. 2008 Can prophylactic breast irradiation contribute to cardiac toxicity in patients with prostate cancer receiving androgen suppressing drugs? Radiat Oncol 3 2 18186924 10.1186/1748-717X-3-2
17. H.J. Ochel 2005 A proposal for the repositioning of prophylactic breast radiotherapy of prostate cancer patients Future Oncol 1 625 629 16556039 10.2217/14796694.1.5.625
18. H. Ozen F. Akyol G. Toktas 2010 Is prophylactic breast radiotherapy necessary in all patients with prostate cancer and gynecomastia and/or breast pain? J Urol 194 519 524 10.1016/j.juro.2010.03.137
19. S. Perdona R. Autorino S. De Placido, et al. 2005 Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial Lancet Oncol 6 295 300 15863377 10.1016/S1470-2045(05)70103-0 1:CAS:528: DC%2BD2MXjs1Krsbo%3D (Pubitemid 40590266)
20. M. Pinkawa M.D. Piroth B. Asadpour, et al. 2009 Neoadjuvant hormonal therapy and external-beam radiotherapy versus external-beam irradiation alone for prostate cancer. A quality-of-life analysis Strahlenther Onkol 185 101 108 19240996 10.1007/s00066-009-1894-y
21. H. van Poppel C.J. Tyrrell K. Haustermans, et al. 2005 Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer Eur Urol 47 587 592 15826748 10.1016/j.eururo.2004.12.003 (Pubitemid 40521901)
22. N. Rupp G. Grünberg 1974 Mamma-Bestrahlung vor Hormongabe bei Patienten mit Prostatakarzinom Strahlentherapie 148 35 38 4439429 1:STN:280:DyaE2M%2FmvVWltw%3D%3D
23. D. Saltzstein P. Sieber T. Morris, et al. 2005 Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole Prostate Cancer Prostatic Dis 8 75 83 15685254 10.1038/sj.pcan.4500782 1:CAS:528:DC%2BD2MXisVShsrg%3D
24. W.A. See M. Wirth D.G. McLeod, et al. 2002 Bicalutamide as immediate therapy, either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: First analysis of the Early Prostate Cancer Program J Urol 168 429 435 12131282 10.1016/S0022-5347(05)64652-6 1:CAS:528:DC%2BD38XmtFWhtLs%3D (Pubitemid 34793266)
25. L. Souhami K. Bae M. Pilepich, et al. 2009 Impact of the duration of adjuvant hormonal therapy in patients with locally advanced prostate cancer treated with radiotherapy: a secondary analysis of RTOG 85-31 J Clin Oncol 27 2137 2143 19307511 10.1200/JCO.2008.17.4052
26. C.J. Tyrrell H. Payne T.L. Tammela, et al. 2004 Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia Int J Radiat Oncol Biol Phys 60 476 483 15380582 10.1016/j.ijrobp.2004.03.022 (Pubitemid 39233467)
27. R.J. Wassersug J.L. Oliffe 2009 The social context for psychological distress from latrogenic gynecomastia with suggestions for its management J Sex Med 6 989 1000 19175864 10.1111/j.1743-6109.2008.01053.x
28. F. Wenz T. Martin D. Böhmer, et al. 2010 The German S3 guideline prostate cancer: aspects for the radiation oncologist Strahlenther Onkol 186 531 534 20890742 10.1007/s00066-010-2193-3
29. A. Widmark 2003 Foss antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3 Urology 61 145 151 12559286 10.1016/S0090-4295(02)02107-6 1:STN:280:DC%2BD3s%2FltFWqsg%3D%3D (Pubitemid 36151731)
30. H. Wolf P.O. Madsen H. Vermund 1969 Prevention of estrogen-induced gynecomastia by external irradiation J Urol 102 607 609 5347770 1:STN:280:DyaE3c%2FisFeqtQ%3D%3D